The pronounced elevation of CXCL9 and CCL2, chemokines that recruit T cells and monocytes to sites of inflammation, might have amplified the immune response and contributed to the severity of the CRS [5,10,11,12,13]. The gene discussed is CCL2; the disease is congenital rubella syndrome.